BioSpace News Archive

Lone Star Bio

Tidal Medical Technologies receives FDA Emergency Use Authorization (EUA) for the use of InSee for tracking of incentive spirometers usage in treatment of respiratory conditions in COVID-19 patients.

Tidal Medical Technologies today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for emergency use of the InSee incentive spirometer accessory for quantitatively tracking patient usage of Vyaire Medical’s AirLife incentive spirometer, as an aid in treatment of respiratory conditions by patients with Coronavirus Disease 2019 (COVID-19) in hospital settings.

July 14, 2021
·
3 min read
Genetown

OM1 Launches Multiple Sclerosis Registry with More than 20,000 Patients Prospectively Followed with Deep Clinical Data

OM1, a leading real-world data, outcomes and technology company with a focus on chronic diseases, today announced the launch of its multiple sclerosis (MS) registry.

July 14, 2021
·
2 min read
BioIVT Opens New, Larger UK Blood Donor Center on Imperial College London’s White City Campus

BioIVT’s new blood donor center is located in White City, a biotech hub, together with cell therapy, gene therapy, and pharmaceutical companies.

July 14, 2021
·
2 min read
Genetown

AXONIS Therapeutics Announces $5 Million in Funding; Provides Update on Progress Advancing Novel Therapeutics for Neurological Disorders

AXONIS Therapeutics, Inc., an emerging biotechnology company advancing breakthrough research to develop therapies for neurological disorders, today announced it has secured an additional $5 million in funding.

July 14, 2021
·
4 min read